FDA Panel vs. Scientists: The BPC-157 Compounding Status Battle That Could Reshape US Peptide Access
A July 2026 FDA advisory panel vote supporting broader patient access to compounded BPC-157 has sparked a direct conflict with the agency's own scientists over...
